Doxylamine succinate and pyridoxine hydrochloride
NDC 0591-2132, Doxylamine succinate and pyridoxine hydrochloride, tablet, delayed release, from Actavis Pharma, Inc..
- Product NDC
- 0591-2132
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205811
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXYLAMINE SUCCINATE10 mg/1
- PYRIDOXINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Analogs/Derivatives [Chemical/Ingredient]; Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]; Vitamin B 6 [Chemical/Ingredient]; Vitamin B6 Analog [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0591-2132-01 | 00591213201 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2132-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3670d66e-c1e4-42ce-8760-c3d5accad925NADAC price for package 00591213201
GET /v1/drugs/nadac/00591213201
Use it
Look up 0591-2132 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0591-2132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.